Klinická farmakologie a farmacie – 1/2020

www.klinickafarmakologie.cz  / Klin Farmakol Farm 2020; 34(1): 12–15 / KLINICKÁ FARMAKOLOGIE A FARMACIE 15 HLAVNÍ TÉMA Nová možnost lokální anestezie v zubním lékařství ncbi.nlm.nih.gov/compound/Tetracaine (accessed on July 23, 2019). 4. Statni ustav pro kontrolu léiv. Databaze leku. [cit. 20190405]. Dostupne na www: http://www.sukl.cz/mo‑ dules/medication/detail.php?kod=0057655 5. Statni ustav pro kontrolu léiv. Databaze leku. [cit. 20190625]. Dostupne na www: http://www.sukl.cz/modules/ medication/detail.php?kod=0216273 6. Kovanaze clinical pharmacology review, Dostupné na www: https://www.fda.gov/media/98992/download 7. Feehan HF, Mancusi UA. The use of cocaine as a topical an‑ esthetic in nasal surgery. A survey report. Plast Reconstr Surg. 1976 Jan; 57(1): 62–65. 8. Campbell JP, Campbell CD, Warren DW, et al. Comparison of the Vasoconstrictive and Anesthetic Effects of Intranasa‑ lly Applied Cocaine vs. Xylometazoline/Lidocaine Solution. Otolaryngol Head Neck Surg. 1992 Nov; 107(5): 697–700. 9. Tarver CP, Noorily AD, Sakai CS. A comparison of cocaine vs. lidocaine with oxymetazoline for use in nasal proce‑ dures. Otolaryngol Head Neck Surg. 1993 Oct; 109(4): 653–659. 10. Noorily AD, Otto RA, Noorily SH. Intranasal Anesthetic Effects of Lidocaine and Tetracaine Compared. Otolaryngol Head Neck Surg. 1995 Oct; 113(4): 370–374. 11. Ciancio SG, Marberger AD, Ayoub F, et al. Comparison of 3 intranasal mists for anesthetizing maxillary teeth in adults. J Am Dent Assoc. 2016 May; 147(5): 339–347. 12. Saraghi M, Hersh EV. Intranasal tetracaine and oxymeta‑ zoline spray for maxillary local anesthesia without injections. Gen Dent. 2017 Mar‑Apr; 65(2): 16–19. 13. Hersh EV, Saraghi M, Moore PA. Intranasal tetracaine and oxymetazoline: a newly approved drug formulation that pro‑ vides maxillary dental anesthesia without needles. Curr Med Res Opin. 2016 Nov; 32(11): 1919–1925. 14. Cacek AT, Gobburu JV, Gopalakrishnan M. Population Pharmacokinetics of an Intranasally Administered Com‑ bination of Oxymetazoline and Tetracaine in Healthy Vo‑ lunteers. J Clin Pharmacol. 2017 Feb; 57(2): 247–254. 23. 15. Capetillo J, Drum M, Reader A, et al. Anesthetic Efficacy of Intranasal 3% Tetracaine plus 0.05% Oxymetazoline (Ko‑ vanaze) in Maxillary Teeth. J Endod 2019 Mar; 45(3): 257–262. 16. Giannakopoulos H, Levin LM, Chou JC, et al. The cardi‑ ovascular effects and pharmacokinetics of intranasal tetra‑ caine plus oxymetazoline: preliminary findings. J Am Dent Assoc. 2012 Aug; 143(8): 872–880.

RkJQdWJsaXNoZXIy NDA4Mjc=